Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacterium
Authors:
- 7 January 2015
- journal article
- Published by Spandidos Publications in Biomedical Reports
- Vol. 3 (2) , 261-265
Abstract
The prevalence of extended‑spectrum β‑lactamases (ESBLs) is due to the extensive usage of the extended‑spectrum cephalosporins and leads to huge financial loss worldwide, whilst presenting a challenge to the clinical treatment. The aim of the present study was to delineate the frequency of ESBL occurrence in Enterobacteriaceae and confirm the SHV genotype. A random collection of 153 Escherichia coli isolates (E. coli) and 70 Klebsiella pneumoniae isolates were tested. The amplification products obtained by polymerase chain reaction were sequenced. Isolates with novel mutations were transformed to E. coli DH5α. The minimum inhibitory concentration (MIC) was obtained by a microdilution method. The relevance ratio of ESBL was 67.7% and the proportion of the SHV β‑lactamase gene (blaSHV) was 18.5%. A new genotype of β‑lactamase was demonstrated and submitted to GenBank. A total of 12 mutational sites were found in 28 ESBL‑producing isolates, including four nonsense mutations. Sensitive‑rates of 28 ESBL‑producing isolates to imipenem were 100%, and resistant‑rates to penicillin, amoxicillin and oxacillin were 100%. The MIC of DH5α‑F8 to penicillin, oxacillin, cefoxitin, cefotaxime, cefepime, cefoperazone/sulbactam, imipenem and netilmicin was 512, 512, 2, 0.03, 0.06, 4, 0.015 and 32 respectively. In conclusion, ESBL and SHV‑28 is the most prevalent bla. Imipenem is the most effective antibiotic to ESBL, and the 4th‑generation cephalosporins and β‑lactamase inhibitor compound are also effective. ESBL is mediated by plasmids and able to spread among different Enterobacteriaceae. In conclusion, new mutations of the blaSHV gene exist from at least 2010.Keywords
This publication has 25 references indexed in Scilit:
- Molecular Characterization of Resistance to Extended-Spectrum Cephalosporins in Clinical Escherichia coli Isolates from Companion Animals in the United StatesAntimicrobial Agents and Chemotherapy, 2011
- Transmission of a Klebsiella pneumoniae clone harbouring genes for CTX-M-15-like and SHV-112 enzymes in a neonatal intensive care unit of a Kuwaiti hospitalJournal of Medical Microbiology, 2010
- Extended-spectrumβ-Lactamases: Implications for the Clinical Laboratory and TherapyAnnals of Laboratory Medicine, 2008
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- Screening for Extended-Spectrum Beta-Lactamase-Producing Pathogenic Enterobacteria in District General HospitalsJournal of Clinical Microbiology, 2005
- Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-LactamasesAntimicrobial Agents and Chemotherapy, 2003
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Extended-spectrum β-lactamases: how big is the problem?Clinical Microbiology and Infection, 2000
- Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial EraScience, 1992
- Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamaseJournal of Antimicrobial Chemotherapy, 1987